Oncoinvent A

Oncoinvent A OCF Margin

The Operating Cash Flow Margin of Oncoinvent A (ONCIN.OL) as of Nov 7, 2026 is -467.37 %. In the previous year, Operating Cash Flow Margin was -18,070.99 % — a change of -97.41% (higher).

OCF Margin

-467.37 %

YoY

-97.41%

Last updated:

Operating Cash Flow Margin of Oncoinvent A is 2025 -467.37 % . Operating Cash Flow Margin of Oncoinvent A was 2024 -18,070.99 % . It decreases by -97.41% higher compared to the previous year.

The Oncoinvent A OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
-7,995.97 NOK
Jan 1, 2019
-2,097.56 NOK
Jan 1, 2020
-38,983.36 NOK
Jan 1, 2021
-39,191.21 NOK
Jan 1, 2022
-74,095.37 NOK
Jan 1, 2023
-39,015.25 NOK
Jan 1, 2024
-18,070.99 NOK
Jan 1, 2025
-467.37 NOK
The Oncoinvent A OCF Margin history
YEAROCF MarginYoY
-467.37 %-97.41%
-18,070.99 %-53.68%
-39,015.25 %-47.34%
-74,095.37 %+89.06%
-39,191.21 %+0.53%
-38,983.36 %+1,758.51%
-2,097.56 %-73.77%
-7,995.97 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Oncoinvent A Stock analysis

What does Oncoinvent A do? Oncoinvent ASA is a radiopharmaceutical company based in Oslo, Norway, operating within the Health Care sector. Listed on 13 December 2024, the firm employs 46 people and focuses on developing alpha-emitting radiotherapeutics for cancer patients. Its primary product, Radspherin, is an alpha-emitting radioactive microsphere therapy designed to treat metastatic cancers in body cavities. This suspension of calcium carbonate microspheres labelled with Radium-224 targets residual micro-metastases on intracavitary surfaces and in liquids after surgery, aiming to spare deeper organs from harmful radiation doses. Oncoinvent A is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oncoinvent A stock

Operating Cash Flow Margin of Oncoinvent A is -467.37 % in 2025.

Operating Cash Flow Margin of Oncoinvent A changed from -18,070.99 % to -467.37 %, representing a -97.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Oncoinvent A since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Oncoinvent A with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Oncoinvent A

All Key Metrics — Oncoinvent A